HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.
复制标题
DOI:
10.1002/pds.5507
复制
发表时间:
2023-01
影响因子:
2.6
通讯作者:
中科院分区:
文献类型:
--
作者:
Ambiguity in communication of key study parameters limits the utility of real-world evidence (RWE) studies in healthcare decision-making. Clear communication about data provenance, design, analysis and implementation is needed. This would facilitate reproducibility, replication in independent data, and assessment of potential sources of bias. The International Society for Pharmacoepidemiology (ISPE) and International Society of Pharmacoeconomics and Outcomes Research (ISPOR) convened a joint task force, including representation from key international stakeholders, to create a harmonized protocol template for RWE studies that evaluate a treatment effect and are intended to inform decision-making. The template builds on existing efforts to improve transparency and incorporates recent insights regarding the level of detail needed to enable RWE study reproducibility. The overarching principle was to reach for sufficient clarity regarding data, design, analysis, and implementation to achieve 3 main goals. One, to help investigators thoroughly consider, then document their choices and rationale for key study parameters that define the causal question (e.g. target estimand), two, to facilitate decision-making by enabling reviewers to readily assess potential for biases related to these choices, and three, to facilitate reproducibility. Recognizing that the impact of this harmonized template relies on uptake, we have outlined a plan to introduce and pilot the template with key international stakeholders over the next 2 years. The HARmonized Protocol Template to Enhance Reproducibility (HARPER) helps to create a shared understanding of intended scientific decisions through a common text, tabular and visual structure. The template provides a set of core recommendations for clear and reproducible RWE study protocols and is intended to be used as a backbone throughout the research process from developing a valid study protocol, to registration, through implementation and reporting on those implementation decisions. Ambiguity in communication of key study parameters limits the utility of real-world evidence (RWE) studies in healthcare decision-making. The International Society for Pharmacoepidemiology (ISPE) and International Society of Pharmacoeconomics and Outcomes Research (ISPOR) convened a joint task force to create a harmonized protocol template for RWE studies. The template builds on existing efforts to improve transparency and incorporates recent insights regarding the level of detail needed to enable study reproducibility. The overarching principle was to reach for sufficient clarity to achieve 3 main goals. One, to help investigators thoroughly consider, then document their choices and rationale for key study parameters that define the causal question, two, to facilitate decision-making by enabling reviewers to readily assess potential for biases related to these choices, and three, to facilitate reproducibility. The HARmonized Protocol Template to Enhance Reproducibility (HARPER) helps to create a shared understanding of intended scientific decisions through a common text, tabular and visual structure. The template provides a set of core recommendations for clear and reproducible RWE study protocols and is intended to be used as a backbone throughout the research process from developing a valid study protocol, to registration, through implementation and reporting on those implementation decisions.
登录
查看更多内容
影响因子:
2.6
作者:
Berger, Marc L.;Sox, Harold;Daniel Mullins, C.
通讯作者:
Daniel Mullins, C.
DOI:
10.18553/jmcp.2016.22.10.1107
发表时间:
2016-10-01
影响因子:
2.1
作者:
Dreyer, Nancy A.;Bryant, Allison;Velentgas, Priscilla
通讯作者:
Velentgas, Priscilla
影响因子:
37.8
作者:
Franklin JM;Patorno E;Desai RJ;Glynn RJ;Martin D;Quinto K;Pawar A;Bessette LG;Lee H;Garry EM;Gautam N;Schneeweiss S
通讯作者:
Schneeweiss S
影响因子:
6.7
作者:
Cocoros, Noelle M.;Arlett, Peter;Toh, Sengwee
通讯作者:
Toh, Sengwee
影响因子:
4.5
作者:
Berger, Marc L.;Martin, Bradley C.;Crown, William
通讯作者:
Crown, William